Hospital de São João

Porto 4202-451

0 studies enrolling now · 6 studies all time

What they study most

Aortic Valve Disease, Aortic Valve Disorder, HIV Infections, Multiple Sclerosis, Ovarian Cancer, Pulmonary Disease, Chronic Obstructive, Renal Cell Carcinoma

Studies at this site

• Trifecta™ GT Post Market Clinical Follow-up — Completed
• Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients — Completed
• A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol. — Completed
• Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse — Stopped early
• Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase — Completed
• Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects — Completed